AAPL346.04+2.05 (+0.60%) ▲|ABBV284.56-0.24 (-0.09%) ▼|ABT102.44+1.93 (+1.92%) ▲|ACN251.79+11.53 (+4.80%) ▲|ADBE269.35+14.29 (+5.60%) ▲|AMAT379.67-29.27 (-7.16%) ▼|AMD510.23-42.50 (-7.69%) ▼|AMGN448.43+10.09 (+2.30%) ▲|AMT180.83+3.19 (+1.80%) ▲|AMZN250.25-12.13 (-4.62%) ▼|AVGO324.69-13.11 (-3.88%) ▼|AXP324.15+0.54 (+0.17%) ▲|BA188.42-3.86 (-2.01%) ▼|BAC50.92+0.14 (+0.28%) ▲|BKNG161.73+3.35 (+2.12%) ▲|BLK1,140.28-9.32 (-0.81%) ▼|BMY63.40+2.28 (+3.73%) ▲|BNY144.39-1.47 (-1.00%) ▼|BRK-B549.50+10.51 (+1.95%) ▲|C122.00-1.85 (-1.49%) ▼|CAT700.46-39.75 (-5.37%) ▼|CL97.26+3.86 (+4.13%) ▲|CMCSA22.72+0.64 (+2.91%) ▲|COF203.62-3.05 (-1.47%) ▼|COP146.03+0.36 (+0.25%) ▲|COST1,013.81+15.50 (+1.55%) ▲|CRM249.84+8.06 (+3.33%) ▲|CSCO104.94-2.33 (-2.17%) ▼|CVS94.12+1.34 (+1.44%) ▲|CVX226.22-0.57 (-0.25%) ▼|DE639.41+2.87 (+0.45%) ▲|DHR229.92-3.94 (-1.69%) ▼|DIS112.61+0.78 (+0.70%) ▲|DUK124.83+4.16 (+3.45%) ▲|EMR158.07-5.04 (-3.09%) ▼|FDX302.92+4.69 (+1.57%) ▲|GD348.39+3.68 (+1.07%) ▲|GE290.18-5.70 (-1.93%) ▼|GEV822.47-103.45 (-11.17%) ▼|GILD156.80+3.23 (+2.10%) ▲|GM76.72+0.61 (+0.79%) ▲|GOOG320.83-10.12 (-3.06%) ▼|GOOGL324.44-10.33 (-3.08%) ▼|GS887.73-16.99 (-1.88%) ▼|HD325.72+11.58 (+3.69%) ▲|HON215.32+0.59 (+0.27%) ▲|IBM249.87-1.59 (-0.63%) ▼|INTC86.11-6.85 (-7.37%) ▼|INTU353.97+18.36 (+5.47%) ▲|ISRG441.26+13.14 (+3.07%) ▲|JNJ268.91+11.13 (+4.32%) ▲|JPM334.80-0.39 (-0.12%) ▼|KO94.84+2.16 (+2.33%) ▲|LIN509.77+9.20 (+1.84%) ▲|LLY1,311.52+40.77 (+3.21%) ▲|LMT585.45+33.94 (+6.15%) ▲|LOW203.10+6.54 (+3.33%) ▲|LRCX231.69-29.12 (-11.17%) ▼|MA631.79+9.17 (+1.47%) ▲|MCD251.63+5.38 (+2.18%) ▲|MDLZ64.91+2.17 (+3.45%) ▲|MDT95.58+2.55 (+2.74%) ▲|META645.44-52.08 (-7.47%) ▼|MMM174.08-0.66 (-0.38%) ▼|MO75.86+2.03 (+2.74%) ▲|MRK147.96-1.92 (-1.28%) ▼|MS183.29-3.73 (-1.99%) ▼|MSFT523.97-8.98 (-1.69%) ▼|MU860.14-53.53 (-5.86%) ▼|NEE81.39+3.11 (+3.97%) ▲|NFLX67.22+2.18 (+3.35%) ▲|NKE38.27+0.74 (+1.96%) ▲|NOW156.69+3.57 (+2.33%) ▲|NVDA212.50-9.47 (-4.27%) ▼|ORCL123.41-5.72 (-4.43%) ▼|PEP138.27+3.57 (+2.65%) ▲|PFE30.25+0.40 (+1.34%) ▲|PG166.12+9.28 (+5.92%) ▲|PLTR197.07-4.65 (-2.31%) ▼|PM200.87+3.41 (+1.73%) ▲|QCOM172.75-5.22 (-2.93%) ▼|RTX192.53+0.93 (+0.49%) ▲|SBUX101.62+2.54 (+2.56%) ▲|SCHW92.21+0.57 (+0.62%) ▲|SO93.28+2.89 (+3.20%) ▲|SPG211.18+5.63 (+2.74%) ▲|T22.68+0.77 (+3.49%) ▲|TMO676.83-17.19 (-2.48%) ▼|TMUS158.27+4.52 (+2.94%) ▲|TSLA377.95-8.53 (-2.21%) ▼|TXN283.23-1.42 (-0.50%) ▼|UBER68.21+0.59 (+0.87%) ▲|UNH424.60+7.60 (+1.82%) ▲|UNP296.04+8.17 (+2.84%) ▲|UPS101.69+2.12 (+2.12%) ▲|USB59.91+0.86 (+1.45%) ▲|V413.95+6.10 (+1.50%) ▲|VZ44.80+1.24 (+2.84%) ▲|WFC83.02+0.60 (+0.73%) ▲|WMT120.45+2.65 (+2.25%) ▲|XOM177.34-0.75 (-0.42%) ▼|AAPL346.04+2.05 (+0.60%) ▲|ABBV284.56-0.24 (-0.09%) ▼|ABT102.44+1.93 (+1.92%) ▲|ACN251.79+11.53 (+4.80%) ▲|ADBE269.35+14.29 (+5.60%) ▲|AMAT379.67-29.27 (-7.16%) ▼|AMD510.23-42.50 (-7.69%) ▼|AMGN448.43+10.09 (+2.30%) ▲|AMT180.83+3.19 (+1.80%) ▲|AMZN250.25-12.13 (-4.62%) ▼|AVGO324.69-13.11 (-3.88%) ▼|AXP324.15+0.54 (+0.17%) ▲|BA188.42-3.86 (-2.01%) ▼|BAC50.92+0.14 (+0.28%) ▲|BKNG161.73+3.35 (+2.12%) ▲|BLK1,140.28-9.32 (-0.81%) ▼|BMY63.40+2.28 (+3.73%) ▲|BNY144.39-1.47 (-1.00%) ▼|BRK-B549.50+10.51 (+1.95%) ▲|C122.00-1.85 (-1.49%) ▼|CAT700.46-39.75 (-5.37%) ▼|CL97.26+3.86 (+4.13%) ▲|CMCSA22.72+0.64 (+2.91%) ▲|COF203.62-3.05 (-1.47%) ▼|COP146.03+0.36 (+0.25%) ▲|COST1,013.81+15.50 (+1.55%) ▲|CRM249.84+8.06 (+3.33%) ▲|CSCO104.94-2.33 (-2.17%) ▼|CVS94.12+1.34 (+1.44%) ▲|CVX226.22-0.57 (-0.25%) ▼|DE639.41+2.87 (+0.45%) ▲|DHR229.92-3.94 (-1.69%) ▼|DIS112.61+0.78 (+0.70%) ▲|DUK124.83+4.16 (+3.45%) ▲|EMR158.07-5.04 (-3.09%) ▼|FDX302.92+4.69 (+1.57%) ▲|GD348.39+3.68 (+1.07%) ▲|GE290.18-5.70 (-1.93%) ▼|GEV822.47-103.45 (-11.17%) ▼|GILD156.80+3.23 (+2.10%) ▲|GM76.72+0.61 (+0.79%) ▲|GOOG320.83-10.12 (-3.06%) ▼|GOOGL324.44-10.33 (-3.08%) ▼|GS887.73-16.99 (-1.88%) ▼|HD325.72+11.58 (+3.69%) ▲|HON215.32+0.59 (+0.27%) ▲|IBM249.87-1.59 (-0.63%) ▼|INTC86.11-6.85 (-7.37%) ▼|INTU353.97+18.36 (+5.47%) ▲|ISRG441.26+13.14 (+3.07%) ▲|JNJ268.91+11.13 (+4.32%) ▲|JPM334.80-0.39 (-0.12%) ▼|KO94.84+2.16 (+2.33%) ▲|LIN509.77+9.20 (+1.84%) ▲|LLY1,311.52+40.77 (+3.21%) ▲|LMT585.45+33.94 (+6.15%) ▲|LOW203.10+6.54 (+3.33%) ▲|LRCX231.69-29.12 (-11.17%) ▼|MA631.79+9.17 (+1.47%) ▲|MCD251.63+5.38 (+2.18%) ▲|MDLZ64.91+2.17 (+3.45%) ▲|MDT95.58+2.55 (+2.74%) ▲|META645.44-52.08 (-7.47%) ▼|MMM174.08-0.66 (-0.38%) ▼|MO75.86+2.03 (+2.74%) ▲|MRK147.96-1.92 (-1.28%) ▼|MS183.29-3.73 (-1.99%) ▼|MSFT523.97-8.98 (-1.69%) ▼|MU860.14-53.53 (-5.86%) ▼|NEE81.39+3.11 (+3.97%) ▲|NFLX67.22+2.18 (+3.35%) ▲|NKE38.27+0.74 (+1.96%) ▲|NOW156.69+3.57 (+2.33%) ▲|NVDA212.50-9.47 (-4.27%) ▼|ORCL123.41-5.72 (-4.43%) ▼|PEP138.27+3.57 (+2.65%) ▲|PFE30.25+0.40 (+1.34%) ▲|PG166.12+9.28 (+5.92%) ▲|PLTR197.07-4.65 (-2.31%) ▼|PM200.87+3.41 (+1.73%) ▲|QCOM172.75-5.22 (-2.93%) ▼|RTX192.53+0.93 (+0.49%) ▲|SBUX101.62+2.54 (+2.56%) ▲|SCHW92.21+0.57 (+0.62%) ▲|SO93.28+2.89 (+3.20%) ▲|SPG211.18+5.63 (+2.74%) ▲|T22.68+0.77 (+3.49%) ▲|TMO676.83-17.19 (-2.48%) ▼|TMUS158.27+4.52 (+2.94%) ▲|TSLA377.95-8.53 (-2.21%) ▼|TXN283.23-1.42 (-0.50%) ▼|UBER68.21+0.59 (+0.87%) ▲|UNH424.60+7.60 (+1.82%) ▲|UNP296.04+8.17 (+2.84%) ▲|UPS101.69+2.12 (+2.12%) ▲|USB59.91+0.86 (+1.45%) ▲|V413.95+6.10 (+1.50%) ▲|VZ44.80+1.24 (+2.84%) ▲|WFC83.02+0.60 (+0.73%) ▲|WMT120.45+2.65 (+2.25%) ▲|XOM177.34-0.75 (-0.42%) ▼|
19.5 C
New York
Thursday, October 22, 2026

Tag: disease

newsFORsourcecompanycontentinformation1releasesmarket

New Progress — XellSmart Unveiled Phase I Results of Off-the-Shelf Parkinson’s Disease Cell Therapy at MDS & Completed Blinded Phase II Enrollment

SEOUL, South Korea and SHANGHAI, Oct. 18, 2026 /PRNewswire/ -- New clinical data for XellSmart's off-the-shelf cell therapy for Parkinson's Disease was presented at...

Vivacta Bio and Grit Bio Announce FDA Orphan Drug Designation for In Vivo CAR-T Therapy GT801 in Autoimmune Hemolytic Anemia

SHANGHAI, Oct. 17, 2026 /PRNewswire/ -- Vivacta Biotechnology (Shanghai) Co., Ltd. ("Vivacta Bio"), a company spun out of the in vivo CAR-T platform of...

SKYRIZI® (risankizumab) and RINVOQ® (upadacitinib) Data Highlight Long-Term Clinical and Endoscopic Outcomes Across Inflammatory Bowel Disease (IBD) at UEGW 2026

20 scientific presentations underscore the breadth of AbbVie's leadership in Inflammatory Bowel Disease (IBD) research programsLatest long-term and real-world data with SKYRIZI®(risankizumab) and RINVOQ®...

/C O R R E C T I O N – American Skin Association/

In the news release, AMERICAN SKIN ASSOCIATION ANNOUNCES FORMATION OF ASA EMERGING DERMATOLOGY LEADERS ADVISORY COMMITTEE, issued 14-Oct-2026 by American Skin Association over PR...

Brayton Purcell LLP Welcomes Federal Bill Addressing Artificial Stone Silicosis Epidemic

Silicosis Prevention and Treatment Act would expand screening, treatment, education, and patient care as California artificial stone fabrication workers face a growing number of...

Five Stars. 10,000 Times. IVX Health Celebrates a Major Patient Experience Milestone.

National infusion provider surpasses 10,000 five-star Google reviews across its 160+ ambulatory infusion centers.BRENTWOOD, Tenn., Oct. 16, 2026 /PRNewswire/ -- IVX Health, a national...

AHN Cancer Center Launches RANDY’S Trial, Funded by Community Support and Inspired by a Firefighter’s Legacy

Clinical trial funded through The Randy & Stephanie Meyer Spread Goodness Fund seeks to expand surgical options for patients facing appendix and other peritoneal...

Brayton Purcell LLP Welcomes Federal Bill Addressing Artificial Stone Silicosis Epidemic

Silicosis Prevention and Treatment Act would expand screening, treatment, education, and patient care as California artificial stone fabrication workers face a growing number of...

Over $4 Million Raised to Brighten Patients’ Futures at Nicklaus Children’s Hospital’s 19th Annual Diamond Ball

This year's signature fundraising event was hosted by radio co-hosts, Enrique Santos and Dayanara Torres and featured powerful patient stories of resilience, innovation and...

CRISPR Market worth $6.12 billion by 2031 – Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., Oct. 16, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the CRISPR Market is projected to reach USD 6.12 billion by 2031 from USD...

Nabsys Launches RepX™ for Repeat Expansion Analysis Ahead of ASHG 2026

New pipeline offers the potential to analyze up to 23 disease-associated repeat expansion loci in a single, low-cost runPROVIDENCE, R.I., Oct. 15, 2026 /PRNewswire/...

Make household safety a priority before temperatures drop

Quality Heating, Cooling, Plumbing & Electric shares easy tips for keeping families and pets safe as National Carbon Monoxide Awareness Month approachesTULSA, Okla., Oct....

Cancer Diagnostics Market to Reach US$ 41.5 Billion by 2031 at 7.2% CAGR, says Wissen Research

Sheridan, WY, Oct. 15, 2026 /PRNewswire/ -- The global cancer diagnostics market is valued at USD 29.3 billion in 2026 and is projected to reach...

Cancer Diagnostics Market to Reach US$ 41.5 Billion by 2031 at 7.2% CAGR, says Wissen Research

SHERIDAN, Wyo., Oct. 15, 2026 /PRNewswire/ -- The global cancer diagnostics market is valued at USD 29.3 billion in 2026 and is projected to reach...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsDisease

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers